The Effects of Sacubitril/Valsartan on Clinical, Biochemical and Echocardiographic Parameters in Patients with Heart Failure with Reduced Ejection Fraction: The “Hemodynamic Recovery”

Background: Sacubitril/valsartan has been shown to be superior to enalapril in reducing the risks of death and hospitalization for heart failure (HF). However, knowledge of the impact on cardiac performance remains limited. We sought to evaluate the effects of sacubitril/valsartan on clinical, bioch...

Descripción completa

Detalles Bibliográficos
Autores principales: Romano, Giuseppe, Vitale, Giuseppe, Ajello, Laura, Agnese, Valentina, Bellavia, Diego, Caccamo, Giuseppa, Corrado, Egle, Di Gesaro, Gabriele, Falletta, Calogero, La Franca, Eluisa, Minà, Chiara, Storniolo, Salvatore Antonio, Sarullo, Filippo Maria, Clemenza, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947355/
https://www.ncbi.nlm.nih.gov/pubmed/31817815
http://dx.doi.org/10.3390/jcm8122165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947355/
https://www.ncbi.nlm.nih.gov/pubmed/31817815
http://dx.doi.org/10.3390/jcm8122165

Ejemplares similares